OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 39.85
-0.70 (-1.73%)
At close: Mar 3, 2026
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 5.24 billion as of March 3, 2026. Its market cap has decreased by -64.29% in one year.
Market Cap
5.24B
Enterprise Value
5.09B
Revenue
49.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.85
Market Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 5.24B, a decrease of -68.94%. That is a compound annual growth rate of -8.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 5.24B | -26.20% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 5.88B |
| Steminent Biotherapeutics | 5.85B |
| Sinphar Pharmaceutical | 5.85B |
| AnnJi Pharmaceutical | 5.61B |
| CHO Pharma | 5.49B |
| Locus Cell | 5.42B |
| Panion & Bf Biotech | 5.36B |
| UnicoCell Biomed | 5.22B |